Malignant pleural mesothelioma

Our plain-English summary of Malignant pleural mesothelioma, by W. Klepetko (Wiener Klinische Wochenschrift, 2016).

The study

• Author: W. Klepetko
• Journal: Wiener Klinische Wochenschrift
• Published: 2016;128(17-18):609-10
• Type of article: Editorial
• Read it: PubMed · Publisher

In plain English

This is a short editorial, not a research study, written on behalf of the Austrian Mesothelioma Interest Group (AMIG). It reports no new data. The author described malignant pleural mesothelioma as a rare but highly malignant disease and stated that no uniform curative treatment strategy had yet been identified. According to the editorial, a group of Austrian physicians formed the AMIG several years earlier to collect data on patients with malignant pleural mesothelioma in Austria. The aim was to better describe how often the disease occurs, how it is treated, and its outcome. The author stated that, with very few exceptions, all larger pulmonology departments and many smaller units in Austria took part. The editorial introduced a series of three papers: one on epidemiology, diagnosis and staging, one on available treatments, and one summarizing the data the AMIG collected. Those papers are not included here. The editorial does not mention asbestos. The author wrote that the AMIG members hoped the series would help improve the situation of these patients in Austria.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: editorial introducing a series of three papers
• Who was studied: No study population. The editorial describes a group that collected data on patients with malignant pleural mesothelioma in Austria. No numbers or dates are given.
• Main results:
  • No study findings are reported. The author described malignant pleural mesothelioma as a rare but highly malignant disease.
  • The author stated that no uniform curative treatment strategy has been identified to date.
  • According to the author, with very few exceptions all larger pulmonology departments, and many smaller units, in Austria contributed to the data collection.
  • The editorial said the third paper in the series summarizes the data the AMIG collected over the last few years. That paper is not part of this text.
• The authors' conclusion: The author stated that the AMIG members hope the series of papers will contribute to improving the situation of patients with malignant pleural mesothelioma in Austria.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma.

Medical terms in this study, explained in our Lexicon: Pleural Mesothelioma.

Related studies

• Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG) — M.A. Hoda, T. Klikovits, et al. (2016)
• Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database — T. Klikovits, M.A. Hoda, et al. (2016)
• Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG) — C. Geltner, P. Errhalt, et al. (2016)
• Distinguishing benign from malignant mesothelial cells in effusions by Glut-1, EMA, and Desmin expression: an evidence-based approach — M. Kuperman, R.R. Florence, et al. (2013)
• Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study — R. Thomas, F. Piccolo, et al. (2015)
• Catheter tract metastasis associated with indwelling pleural catheters — R. Thomas, C.A. Budgeon, et al. (2014)

Browse more research in Wiener Klinische Wochenschrift, or return to medical research.